Supernus Pharmaceuticals ... (SUPN)

NASDAQ: SUPN · Real-Time Price · USD

32.52

0.04 (0.12%)

At close: May 01, 2025, 3:59 PM

32.45

-0.22%

Pre-market: May 02, 2025, 04:59 AM EDT

Supernus Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	69.33M	75.05M	93.12M	203.43M	288.64M	181.38M	192.25M	100.3M	90.12M
Short-Term Investments	384.28M	179.82M	368.21M	136.25M	133.89M	165.69M	163.77M	39.74M	23.72M
Long-Term Investments	n/a	16.62M	93.9M	119.17M	350.36M	591.77M	418.8M	133.64M	75.41M
Other Long-Term Assets	31.53M	8.51M	-10M	-36.12M	8.03M	615K	380K	389K	20.19M
Receivables	142.08M	144.16M	165.5M	148.93M	140.88M	87.33M	102.92M	65.59M	41.53M
Inventory	54.29M	77.41M	91.54M	85.96M	48.33M	26.63M	25.66M	16.3M	16.8M
Other Current Assets	36.09M	16.68M	15.78M	27.02M	18.68M	11.61M	8.89M	6.52M	2.96M
Total Current Assets	686.07M	493.11M	734.15M	601.59M	630.42M	472.64M	493.49M	228.45M	151.4M
Property-Plant & Equipment	11.54M	42.52M	15.17M	16.95M	37.82M	38.35M	4.09M	5.12M	4.34M
Goodwill & Intangibles	638.93M	716.91M	819.48M	902.21M	442.25M	24.84M	31.37M	36.02M	16.49M
Total Long-Term Assets	682M	784.56M	968.36M	1.09B	873.68M	687.64M	484.32M	196.01M	158.16M
Total Assets	1.37B	1.28B	1.7B	1.69B	1.5B	1.16B	977.81M	424.46M	309.57M
Account Payables	4.59M	1.96M	10.54M	9.33M	6.15M	10.14M	3.19M	6.84M	8.05M
Deferred Revenue	n/a	n/a	49.81M	126.25M	122.43M	144.38M	-2.18M	287K	209K
Short-Term Debt	n/a	n/a	401.97M	7.24M	5.32M	3.24M	2.18M	4.28M	n/a
Other Current Liabilities	287.81M	259.18M	251.69M	92.86M	60.5M	21.26M	22.99M	17.03M	63.33M
Total Current Liabilities	292.4M	290.2M	687.96M	315.38M	245.11M	160.59M	161.35M	123M	80.74M
Long-Term Debt	n/a	n/a	n/a	379.25M	375.16M	345.17M	329.46M	22.26M	4.17M
Other Long-Term Liabilities	34.98M	7.8M	42.54M	52.02M	90.16M	28.66M	33.97M	10.58M	31.41M
Total Long-Term Liabilities	39.94M	65.96M	128.35M	557.92M	514.14M	404.27M	363.44M	33.98M	37.07M
Total Liabilities	332.34M	356.16M	816.3M	873.3M	759.24M	564.85M	524.79M	156.98M	117.81M
Total Debt	34.27M	41.53M	437.97M	420.55M	390.33M	375.61M	329.46M	26.54M	4.17M
Common Stock	56K	55K	54K	53K	53K	53K	52K	51K	50K
Retained Earnings	556.43M	482.56M	481.25M	379.92M	326.5M	199.55M	86.49M	-26.82M	-84.29M
Comprehensive Income	-189K	-593K	-3.21M	1.54M	8.97M	7.42M	-3.16M	-747K	-134K
Shareholders Equity	1.04B	921.52M	886.2M	815.85M	744.86M	595.43M	453.02M	267.48M	191.75M
Total Investments	384.28M	196.44M	462.11M	255.41M	484.25M	757.47M	582.57M	173.37M	99.13M